Bioavailability of dihydroergotamine in man (Q42247592)

19 October 2017

Bioavailability of dihydroergotamine in man (English)

1 reference

19 October 2017

1 reference

Little PJ

1

1 reference

19 October 2017

Jennings GL

series ordinal

2

1 reference

19 October 2017

Skews H

series ordinal

3

1 reference

19 October 2017

Bobik A

series ordinal

4

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 June 1982

1 reference

British Journal of Clinical Pharmacology

19 October 2017

1 reference

19 October 2017

13

1 reference

19 October 2017

6

1 reference

19 October 2017

785-790

1 reference

A new technique for recording compliance of human hand veins

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402019

Pindolol pharmacokinetics in relation to time course of inhibition of exercise tachycardia

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402019

Comparative pharmacokinetic investigations with tritium-labeled ergot alkaloids after oral and intravenous administration man

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402019

Involvement of the sodium-potassium pump in the mechanism of postjunctional supersensitivity of the vas deferens of the guinea pig

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402019

Prevention of postoperative venous thromboembolism by means of heparin and dihydroergotamine after hip joint replacement

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402019

Haemodynamic effects of dihydroergotamine in patients with postural hypotension.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402019

Low bioavailability as a cause of apparent failure of dihydroergotamine in orthostatic hypotension.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402019

Comparative Effects of Dihydroergotamine and Noradrenaline on Resistance, Exchange and Capacitance Functions in the Peripheral Circulation

3 July 2018

1 reference

12 December 2020

9-10-dihydroergotamine: production of antibodies and radioimmunoassay

1 reference

12 December 2020

Enhancement of the bioavailability of propranolol and metoprolol by food

1 reference

12 December 2020

Treatment of orthostatic hypotension with dihydroergotamine

1 reference

12 December 2020

Determination of norepinephrine apparent release rate and clearance in humans

1 reference

12 December 2020

Ergotism in a patient with a portosystemic shunt

1 reference

12 December 2020

Interaction between oral propranolol and hydralazine

1 reference

12 December 2020

Low oral bioavailability of dihydroergotamine and first-pass extraction in patients with orthostatic hypotension

1 reference

12 December 2020

10.1111/J.1365-2125.1982.TB01866.X

Identifiers

DOI

1 reference

19 October 2017

1 reference

19 October 2017

PubMed publication ID

7093108

1 reference